Clinical Trial

Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.
Trial Details
NCT Number NCT07752420
Lead Sponsor Green International University
Conditions COPD (With - Without Rehabilitation)
Enrollment 52 participants
Start Date 2026-09-01
Primary Completion 2026-11-15 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07